Cardinal Health is trading 4.57% down at $226.74 in after-hours trading after no verified company-specific catalyst emerged on August 6, 2026.

  • The August 5 chief accounting officer appointment appears unrelated; the next scheduled earnings release is August 11.
  • Broader sentiment was modestly negative, but the Dow’s 0.86% decline does not clearly explain the larger extended-hours move.
  • Further news may emerge before August 7.